← All medicines

Metabolic medicines

Velmanase alfa injection

Independent educational summary · Sources checked November 20, 2026

An enzyme replacement for specified manifestations of alpha-mannosidosis.

Profile scope: Velmanase alfa injection. Confirm the exact product and route; formulations and combination products are not interchangeable.

Possible side effects

Nasal symptoms, fever, headache, or joint discomfort may occur.

Serious risks and warning signs

Severe hypersensitivity, including anaphylaxis, can occur during or after infusion. Breathing difficulty, blue skin, swelling, or marked reaction symptoms needs emergency treatment. Monitoring and reaction-prevention plans must be individualized.

A question for your healthcare team

What observation and emergency-response plan will be used, including after I leave the infusion center?

What to do with this information

Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.

Sources

Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.